Jak tyrosine kinases are activated by interleukins and other growth factors, and promote survival and proliferation of cells in multiple tissues. These kinases are constitutively active in many hematopoietic malignancies and certain carcinomas. We have investigated whether Jak kinases play a role in lymphoma invasion and metastasis. Proliferation and survival of a highly metastatic T-lymphoma was made independent of its constitutively active Jak by expression of active forms of both STAT3 and PI3-kinase. Jak activity was then blocked by the isolated JH2 'pseudokinase' domain of Jak2. In vitro invasion was blocked by the JH2 domain, and the metastatic capacity of the JH2-expressing cells was much reduced. The Jak inhibitor AG490 inhibited invasion as well. Invasion and metastasis of these cells requires activation of the integrin LFA-1 by the CXCR4 chemokine receptor. We show that Jak kinases act downstream of LFA-1. We conclude that Jak kinase activity is essential for lymphoma invasion and metastasis, independent of its role in survival and proliferation, and independent of STAT and PI3K signaling. This indicates that Jak kinases contribute in multiple ways to the induction of malignant behavior.
Introduction
Jak tyrosine kinases are activated by interleukins and other growth factors (Leonard and O'Shea, 1998) . Upon ligand binding, the receptors form oligomers so that associated Jak kinases can activate each other by transphosphorylation. The effector molecules of Jak kinases, including STATs (signal transducers and activators of transcription), regulate survival, proliferation, differentiation and apoptosis (Bromberg, 2002; Hou et al., 2002) . In hematopoietic malignancies, Jak kinases are often constitutively active, due to autocrine interleukins such as IL-6 (Schuringa et al., 2000) and IL-15 (Do¨bbeling et al., 1998) , silencing of negative regulators such as SOCS-1 (Galm et al., 2003) , or oncogenic Abl tyrosine kinase that activates Jak kinases (Xie et al., 2001) . Furthermore, in the fusion protein TEL-Jak2, resulting from a t(9; 12) chromosome translocation, dimerization of the TEL parts enable transphosphorylation and activation of the Jak2 parts (Peeters et al., 1997; Carron et al., 2000) . In addition, constitutive Jak activity has been observed in other cancers such as breast carcinomas (Garcia et al., 2001) .
In Drosophila, a Jak kinase is essential for migration of ovarian epithelial cells (Silver and Montell, 2001) . It is therefore conceivable that the active Jak kinases in tumor cells are involved in migration and invasion, in addition to survival and proliferation. Indeed, T-lymphomas that develop in TEL-Jak2 transgenic mice are highly invasive and disseminate to multiple tissues such as liver and kidneys (Carron et al., 2000) , in line with a possible role of Jak2 in invasion. We use a Tcell hybridoma as a model T-lymphoma. It is highly invasive and disseminates to multiple tissues including liver and kidneys (La Rivie`re et al., 1988 , 1993 , similarly as TEL-Jak2 lymphomas. Their invasion into rat embryo fibroblast (REF) monolayers correlates well with metastatic capacity. Both the chemokine receptor CXCR4 ) and the integrin LFA-1 (Roossien et al., 1989) are essential for this invasion and for metastasis. Invasion is initiated by CXCR4 signals that control migration and activate LFA-1 molecules. Binding of the activated LFA-1 to ICAM-1 or -2 elicits additional signals that stimulate migration. Furthermore, these signals lead to activation of additional LFA-1 molecules, so that the signal is amplified and propagated (for an illustration, see Figure 6 ). The heterotrimeric G-proteins G i (Soede et al., 1998) and G q and the small GTPases Cdc42 and RhoA (Soede et al., 2001) are required downstream of CXCR4, and the tyrosine kinase ZAP-70 downstream of LFA-1 (Soede et al., 1998 (Soede et al., , 1999 . Permanent inactivation of these signal transducers in the T-cell hybridoma cells impaired invasion and metastasis but had no effect on in vitro proliferation or subcutaneous or intraperitoneal growth in vivo, demonstrating the relevance of the invasion signals for metastasis formation by this T-lymphoma.
As in many lymphomas, the survival and proliferation of T-cell hybridomas requires Jak kinase activity. To investigate the role of Jak kinases in invasion, we had to generate cells that grow in the absence of Jak activity, and this was achieved by expressing constitutively active Jak effectors in cells. Using these cells, we show here that Jak kinases are required for invasion, independent of their role in survival and proliferation.
Results

Generation of a T-cell hybridoma with Jak-independent proliferation
Proliferation and survival of lymphoid tumor cells often depends on Jak activity. This is also true for the TAM2D2 T-cell hybridoma studied here, as shown in Figure 1 : proliferation was blocked by the Jak inhibitor AG490 (Meydan et al., 1996) . Indeed, Jak2 was found to be phosphorylated at Y-1007/1008 and is therefore active (data not shown). It was thus necessary to render the cells Jak-independent. To achieve this, we expressed a constitutively active mutant of the Jak effector STAT3, termed STAT3-C (Bromberg et al., 1999) . However, despite high levels of overexpression (see Figure 2c ), the cells did not grow in the presence of AG490 (Figure 1) . A second Jak-activated pathway involves PI3 K (phosphatidylinositol-3-kinase) and protein kinase B (PKB)/Akt (Nguyen et al., 2001) . A p110 PI3K with a CAAX extension, that targets p110 to its substrate in the membrane, is constitutively active (Didichenko et al., 1996) , but TAM2D2 cells expressing p110-CAAX did not grow in AG490 either (Figure 1) . However, the combined expression of STAT3-C and p110CAAX had the desired effect: after a short adaptation period, proliferation in the presence of AG490 was comparable to that of parental TAM2D2 cells (Figure 1 ).
The JH2 'pseudokinase' domain blocks Jak activity Jak kinases are activated upon transphosphorylation of the kinase domain (JH1) by another Jak kinase (2). This implies that the kinase domains can bind to each other. Jak kinases also contain a JH2 domain that is highly homologous to JH1 but has no kinase activity. Deletion of this 'pseudokinase' domain leads to a high basal Jak activity (Saharinen and Silvennoinen, 2002) , and in Drosophila a mutation in the JH2 domain leads to hyperactivation of the hopscotch Jak homologue (Luo et al., 1997) . In the inactive kinase, the JH2 domain is therefore thought to bind to the JH1 kinase domain, thus preventing transphosphorylation and suppressing basal activity. Indeed, the isolated JH2 domain inhibits the kinase activity of the isolated JH1 kinase domain in cells (Saharinen et al., 2000) . We therefore expected that expression of the Jak2 JH2 domain would inhibit Jak activity.
The STAT3-C/p110CAAX-expressing cells were transduced with a retroviral vector containing cDNAs encoding the Jak2 JH2-domain and GFP, separated by an IRES sequence and sorted for high GFP levels ( Figure 2a ) that should correlate with high JH2 levels ( Figure 2b) . To test the effect on Jak activity, we assayed the phosphorylation of STAT3 by Western blotting with a phospho-STAT3 antibody. This was facilitated by the high levels of STAT3-C. Although phosphorylation is not required for activation of this mutant, the appropriate tyrosines are still phosphorylated by Jak kinases. This is shown in Figure 2c : after a short exposure, the endogenous STAT3 is only faintly visible and the phosphorylated STAT3 not at all, whereas the overexpression of STAT-3C is obvious and extensive STAT3 phosphorylation readily detected in the STAT3-C-overexpressing cells. In contrast, the STAT3-C in the STAT3-C/p110CAAX cells expressing the JH2 pseudokinase domain, was virtually not phosphorylated. This shows that Jak activity was almost completely suppressed. The JH2 domain acts by binding to the autophosphorylated 'open' conformation of Jak2. Therefore, in contrast to STAT3, the phosphorylation of Jak2 itself remained the same (data not shown). Despite the complete inhibition of Jak2 activity, we observed no effect of the expressed JH2 domain on the proliferation rate of the STAT3-C/p110CAAX cells. This confirms our conclusion that proliferation and survival of the STAT3-C/p110CAAX cells were completely independent of Jak kinase activity.
The JH2 'pseudokinase' domain blocks invasion
Invasion of the JH2-expressing cells into REF fibroblast monolayers was inhibited by B80%, whereas the expression of only STAT3-C þ p110CAAX did not affect invasiveness (Figure 2d ). Furthermore, when an unsorted population of JH2/GFP-transduced cells was used, the invaded cells, recovered from the monolayers, had low GFP and therefore low JH2 levels, whereas the high GFP/JH2 expressors remained in suspension, showing that the latter cells could not invade (data not shown). Finally, results were confirmed using the specific Jak inhibitor AG490 that inhibited invasion in Figure 1 Effect of active STAT3 and PI3K on proliferation in the presence of AG490. Cells (2 Â 10 5 /ml) were incubated at in a sixwell plate with or without 100 mM AG490, as indicated, and cells were counted at regular intervals. Combined expression of the active STAT3 STAT3-C and PI3K p110CAAX mutants allowed cells, after a lag period, to proliferate in the presence of AG490 at a rate comparable to nontransfected TAM2D2 cells in the absence of AG490 a dose-dependent manner, as shown in Figure 2e . Invasion was not affected if the monolayers were similarly pretreated with AG490. The Jak3-specific inhibitor WHI-P131 (Tibbles et al., 2001 ) had no effect (Figure 2e ), indicating that Jak3 is not required.
Jak activity is required for metastasis
To test the role of Jak kinases in metastasis, we injected the JH2-expressing cells and, as controls, the cells that express only STAT3-C þ p110CAAX as well as the original nontransfected TAM2D2 cells. As shown in Figure 3 , all six mice injected with the TAM2D2 cells were moribund within 5 weeks, with extensive metastasis to liver, kidneys, pancreas and other tissues. Of the mice injected with the STAT3-C/p110CAAX cells, 10/12 mice were moribund within 6 weeks, with similar tissue distribution of metastases. The mice became moribund somewhat later than those injected with the TAM2D2 cells, but the difference was not statistically significant (P ¼ 0.23). Thus, neither the active PI3K nor the active STAT3 affected metastasis. In contrast, as shown in Figure 3 , 8/10 mice injected with the JH2-expressing cells survived for 6 weeks. The difference is highly significant (P ¼ 0.002). These eight mice were completely free of metastases. Two mice did contain metastatic foci in the liver, but much fewer and these few metastases were also much smaller than in the control mice. This shows that inhibition of Jak activity by the JH2 domain causes a considerable reduction in metastasis formation.
GFP levels in cells recovered from one of the two livers that did contain a few metastases were considerably reduced, compared with a sample of the cells kept in culture during these 6 weeks (data not shown). Since GFP expression should correlate with JH2 levels, this suggests selective outgrowth of a minor subpopulation in which Jak kinases were not completely blocked, indicating that metastasis formation is not possible when Jak kinases are completely inactivated. High expression of GFP alone using this retroviral vector In a second experiment, cells were sorted for homogeneous high GFP expression before injection, to remove cells with reduced JH2 levels. The results were similar. Again, 10/12 mice injected with the STAT3-C/ p110CAAX-expressing cells were moribund within 42 days, with very extensive metastasis, especially to the liver. The two remaining mice, examined after 42 days, also had metastatic foci in their livers. Of mice injected with the JH2-expressing cells, 6/11 mice were still healthy after 42 days. In the others, we observed metastasis at an isolated site, for example, in the mandibular gland or a kidney, but none of the 11 mice had liver metastases.
JH2 domain blocks CXCR4-induced LFA-1-dependent migration
The chemokine receptor CXCR4 and the integrin LFA-1 are essential for invasion and metastasis of these cells (Roossien et al., 1989; Zeelenberg et al., 2001) . As extensively described in a previous paper (Soede et al., 1998) , the invasion process can be mimicked in a simplified model: migration towards a low concentration (1 ng/ml) of the CXCR4 ligand CXCL12 (SDF-1) through filters coated with the LFA-1 ligand ICAM-1. All treatments that blocked invasion also inhibited this migration, showing that the underlying mechanisms are similar, if not identical. As shown in Figure 4 (lower panel), this is also true for inhibition of Jak activity. Cells expressing the JH2 domain did not migrate at all, and also AG490 completely blocked this migration. Neither JH2 nor AG490 influenced the surface levels of CXCR4 or LFA-1 (data not shown). When no CXCL12 was added to the lower well, no migration (0.0%) of either TAM2D2 cells or any of the transfectants was seen.
Jak kinase activity is not required for LFA-1-independent migration
In contrast to migration towards low CXCL12 levels, LFA-1 is not required for migration of these cells towards 100 ng/ml CXCL12, as described previously (Soede et al., 1998) . G i protein and Cdc42 are still essential, but for example, RhoA and ZAP-70 are only required for LFA-1-dependent migration (Soede et al., 1998 (Soede et al., , 2001 . For an illustration, see Figure 6 . As shown in Figure 4 (upper panel), Jak kinases are not required for this migration towards 100 ng/ml CXCL12: neither the JH2 domain nor AG490 had a substantial effect. Thus, inhibition by the JH2 domain or AG490 is not due to a general or indirect effect or toxicity. Migration towards 100 ng/ml CXCL12 is completely blocked by the G i protein inhibitor pertussis toxin (Soede et al., 1998) . The lack of inhibition by JH2 domain and AG490 argues against a role of Jak kinases upstream of G i proteins, as has been proposed by others (Vila-Coro et al., 1999) .
Jak kinase activity is required for LFA-1-induced LFA-1 activation
We previously showed that the ZAP-70 tyrosine kinase is required for invasion and metastasis (Soede et al., 1998) . ZAP-70 acts downstream of LFA-1. One of its effects is the activation of additional LFA-1 molecules ) were injected into a tail vein of Balbc/nude mice; six mice with nontransduced TAM2D2 cells, 12 with STAT3-C/p110CAAX-expressing cells, and 10 with cells expressing STAT3-C þ p110CAAX þ the JH2 domain. Mice were autopsied when moribund or after 42 days and examined for macroscopically visible metastases. Shown in the 'survival curve' are the days at which mice became moribund. Mice that were still healthy after 42 days contained no macroscopically visible metastases Figure 4 Role of Jak kinases in migration towards CXCL12. Cells in Transwells were allowed to migrate towards 100 ng/ml CXCL12 in the lower well through uncoated filters (upper panel), or towards 1 ng/ml CXCL12 through filters coated with ICAM-1 (lower panel). AG490 pretreatment was as in the invasion assays (see Figure 2) . Shown are the percentages of cells that have migrated to the lower well. These are the means of two independent experiments, performed in duplicate (for illustration, see Figure 6 ). This process is similar to aggregation induced by LFA-1 antibody (Soede et al., 1999) . Nonsaturating concentrations are used so that the signal triggered by the antibody can activate other LFA-1 molecules that are not occupied by the antibody. The activated LFA-1 then binds to ICAM-2 on adjacent cells, as shown by the complete inhibition of aggregation by either LFA-1 or ICAM-2 antibodies (Soede et al., 1999) . Despite the expression of both LFA-1 and ICAM-2, the cells normally do not aggregate because LFA-1 is not active. Aggregation is therefore a sensitive assay for LFA-1 activation. Direct assessment of conformational changes in LFA-1, as described for certain antibodies against human LFA-1, are unfortunately not possible since such antibodies are not available for mouse LFA-1. Aggregation is blocked in cells expressing a dominant-negative truncated ZAP-70 and by the ZAP-70 inhibitor piceatannol, showing that the ZAP-70 tyrosine kinase is required for the LFA-1 activation signal (Soede et al., 1999) . As shown in Figure 5 , cells expressing the JH2 domain did not aggregate at all, whereas the control STAT3-C/ p110CAAX-expressing cells aggregated similarly as TAM2D2 cells. Furthermore, aggregation of TAM2D2 cells was strongly inhibited by AG490. This shows that Jak kinases are involved in signals downstream of LFA-1.
Discussion
Jak kinases play a pivotal role in the induction and maintenance of malignancy in many hematopoietic tumors as well as certain carcinomas, by promoting survival and proliferation (Bromberg, 2002) . We show here for a T-lymphoma that Jak kinase activity is also required for invasion and thereby for metastasis, independent of its role in survival and proliferation. This conclusion is based on the inhibition by the JH2 pseudokinase domain of Jak2. This acts as an autoinhibitory domain in the Jak kinase molecule by binding to the JH1 kinase domain (Saharinen and Silvennoinen, 2002) . We expressed the JH2 domain and found that this completely blocked Jak activity, as assessed by phosphorylation of STAT3. The role of Jak kinases in migration and invasion was confirmed by the similar effects of the Jak inhibitor AG490. Inhibition was not caused by general toxic effects, since LFA-1-independent migration towards high levels of CXCL12 (SDF-1) was not affected. The (pseudo)kinase domains of different Jak kinases can interact (Saharinen et al., 2000; Saharinen and Silvennoinen, 2002) so that the Jak2 JH2 domain can probably also block other Jak kinases. A Jak3 inhibitor did not affect invasion, but Jak1 and Tyk2 cannot be excluded as yet. However, Jak2 is the most likely candidate, because of its direct interaction with CXCR4.
Jak2 was reported to bind to CXCR4 (Vila-Coro et al., 1999) and we confirmed this for the TAM2D2 cells (data not shown). Jak2 phosphorylation of the CXCR4 DRY motif was proposed to be required for binding of the G i heterotrimeric G-protein (Vila-Coro et al., 1999; Soriano et al., 2003) . Since G i is essential for chemotaxis, Jak2 should then be essential as well. Indeed, AG490 has been reported to inhibit chemotaxis towards CXCL12 of MOLT4T cells (Vila-Coro et al., 1999) and hematopoietic stem cells (Zhang et al., 2001) . In contrast, we found that inhibition of Jak activity by either JH2 or AG490 had little or no effect on the LFA-1-independent migration towards 100 ng/ml CXCL12, which is completely blocked by the G i inhibitor pertussis toxin (Soede et al., 1998) . This argues against a general requirement of Jak kinases for G i activation in chemotaxis. Furthermore, deletion of the DRY motif does not prevent G i binding (Roland et al., 2003) , which also argues against that notion.
In addition to Jak kinases, as described here, the ZAP-70 tyrosine kinase is also required for invasion and metastasis of the T-cell hybridoma (Soede et al., 1998) . ZAP-70 is activated downstream of LFA-1 (see Figure 6 ) and involved in propagation of the Figure 5 Role of Jak kinases in LFA-1-induced aggregation. Cells were treated with a nonsaturating concentration (0.2 mg/ml) of M17/4 mAb against LFA-1, and shaken for 2 h at low speed. Dimerization of LFA-1 by the antibody generates a signal that leads to activation of other LFA-1 molecules that are not occupied by antibody. These activated LFA-1 molecules bind to ICAM-2 on adjacent cells, so that the cells aggregate (left panels). Cells expressing the JH2 domain did not aggregate and the Jak inhibitor AG490 blocked aggregation (right panels) LFA-1 signal which leads to activation of additional LFA-1 molecules (Soede et al., 1999 ). An assay for this phenomenon is the aggregation of cells by LFA-1 antibodies at nonsaturating concentrations, that is, when only part of the LFA-1 molecules is occupied by antibody. The signal triggered by antibody-induced LFA-1 dimerization leads to the activation of the nonoccupied LFA-1 molecules, which then bind to ICAM-2 on adjacent cells. This aggregation depends on ZAP-70 and requires both SH2 domains (Soede et al., 1999) , indicating that ZAP-70 must bind to an ITAM sequence, as in the T-cell receptor (TCR) zeta-chain (Chan and Shaw, 1995) . However, the TAM2D2 cells have lost expression of the TCR and associated ITAMcontaining chains, so ZAP-70 must bind to another ITAM-containing protein. Furthermore, the TCR ITAMs are phosphorylated by the Src-like kinases Fyn and Lck (Chan and Shaw, 1995) , which have no role in T-cell hybridoma invasion (Soede et al., 1998) . Based on the inhibition of aggregation by the JH2 domain and AG490, we propose that the ITAM is phosphorylated by a Jak kinase. Indeed, Jak2 phosphorylates the ITAM sequence in the adaptor protein STAM (Takeshita et al., 1997) , which is a major candidate for being the putative ITAM-containing protein. The signaling steps required for invasion, and the step in which Jak kinase activity is proposed to be involved, are illustrated in Figure 6 .
Materials and methods
Cells
The mouse T-cell hybridoma TAM2D2 was cultured as described previously (La Rivie`re et al., 1988) . Transfectants were cultured in medium supplemented with 2 mg/ml neomycin (GIBCO/Invitrogen, Carlsbad, CA, USA), 0.3 mg/ml zeocin (Invitrogen) or 0.4 mg/ml puromycin (Sigma, St Louis, MO, USA). Rat embryo fibroblasts (REFs) were cultured in DMEM medium (GIBCO BRL, Paisley, Scotland, UK) with 10% newborn calf serum (GIBCO/Invitrogen) and used for invasion assays between passages 5 and 15. Antibodies STAT3 antibodies (against amino acids (aa) 50-240) were from Santacruz Inc., (Santacruz, CA, USA), phospho-(Y-705)-STAT3 antibodies from Cell Signaling (Beverly, MA, USA), Jak2 antibodies (against aa 758-776 in the JH2 pseudokinase domain) from Sigma, and the monoclonal antibodies (mAb) AC-15 against beta-actin from Abcam (Cambridge, UK). Western blots were incubated for 1 h with antibodies, followed by horseradish peroxidase-coupled second antibody (Amersham Life Sciences, Little Chalfont, UK), and developed by enhanced chemiluminescence (ECL kit, Amersham).
Jak kinase inhibitor
AG490 was from Calbiochem (San Diego, CA, USA). Cell were pretreated for 2.5 h, and washed free of AG490 immediately before the assay. Effects on proliferation were assessed in the continued presence of 100 mM AG490.
Generation and transduction of DNA constructs
The constitutively active STAT3 mutant STAT3-C (Bromberg et al., 1999) was introduced into the retroviral vector pLZRSzeo (Michiels et al., 2000) . PI3K p110-alpha, with a C-terminal CAAX (CVLS) sequence (Didichenko et al., 1996) , termed p110CAAX, was in pLZRS-neo. The mouse Jak2 JH2 domain cDNA, with an added 5 0 Kozak sequence, was generated by RT-PCR from TAM2D2 cells, and cloned into pLZRS-IRESpuroEGFP. This contains a cDNA encoding a puro-EGFP fusion protein, and an IRES so that JH2 and EGFP are in one bicistronic mRNA. The vectors were transfected by calciumphosphate precipitation into Phoenix cells. After 8 h, the medium was refreshed and supernatant, collected after 48 h, was used to infect TAM2D2 cells. Selection drugs were added 3 days later.
Invasion assay
Invasion assays were performed as described (La Rivie`re et al., 1988) . TAM2D2 cells were added to REF monolayers in 24-well plates in serum-free medium. After incubation for 1 h at 371C and 5% CO 2 , monolayers were washed and fixed with 2% paraformaldehyde. Invaded cells were counted using phase contrast microscopy, and the percentage of invaded cells calculated from the average of number of cells per field.
Metastasis assay
TAM2D2 cells (10 6 ) in 0.2 ml. PBS with 1 mM CaCl 2 and 1 mM MgCl 2 , were injected into a tail vein of syngeneic 2-3-monthold BalbC/nude mice. Animals were autopsied when moribund or after 42 days and examined macroscopically for the Figure 6 The role of Jak kinase in signaling steps required for invasion. Schematic illustration of the signals involved: (1) chemotaxis signals, sufficient for LFA-1-independent migration towards 100 ng/ml CXCL12. G i protein and Cdc42 are essential, Jak kinase activity is not; (2) activation of LFA-1 by SDF-1-bound CXCR4, RhoA is essential (in addition to G i and Cdc42); (3) signals downstream of ICAM-bound activated LFA-1. The ZAP-70 tyrosine kinase is essential. These signals promote migration and lead to activation of additional LFA-1 molecules, so that the signal can be amplified and propagated. In this step, Jak kinase is required presence of metastases. The statistical significance of differences between survival curves was tested using the KaplanMeier log-rank test.
Migration assay
Migration was assayed in 5 mm pore Transwells, as described (Soede et al., 1998) . For LFA-1-dependent migration, filters were coated with 3 mg/ml soluble ICAM-1 and 0.1% ovalbumin. The lower chamber contained 250 ml RPMI with 0.1% ovalbumin and 1 ng/ml CXCL12 (Pepro Tech, Rocky Hill, NJ, USA). For LFA-1-independent migration, the filters were only coated with 0.1% ovalbumin, and the lower well contained 100 ng/ml CXCL12. The upper chamber contained 150 ml medium with 10 5 cells. After 2 h at 371C and 5% CO 2 , the migrated cells in the lower chamber were counted.
Aggregation assay
The aggregation assay was as described (Soede et al., 1999) . Briefly, M17/4 mAb against LFA-1 was added to TAM2D2 cells (2 Â 10 6 /ml in HBSS, pH 7.0, with 20 mM HEPES, 0.35 g/l NaHCO 3 , 1 mM CaCl 2 and 1 mM MgCl 2 ) to a final concentration of 0.2 mg/ml, which is nonsaturating. The volume was 0.5 ml, in 10 ml tubes. The tubes were shaken at low speed in a water bath at 371C for 2 h. Using a wide-bore pipette, suspensions were dispersed, transferred to a dish and photographed.
